Access to biologic therapy, such as omalizumab, is a significant barrier for CSU patients in Latin America, despite high disease knowledge. Participants in the pilot program had high baseline ...

The chronic hepatitis D virus market is expected to grow steadily, driven by a relatively small pipeline of emerging therapies. Leading candidates, such as Brelovitug from Bluejay Therapeutics and the ...

TFOS DEWS III emphasizes matching dry eye treatments to specific mechanisms such as lipid imbalance, osmolarity, and glycocalyx failure.

Mohs microscopic surgery and image-guided superficial radiation therapy (IG-SRT) demonstrate high cure rates for non-melanoma ...

By reinforcing exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and ...

Objectives To examine the associations between the inflammatory potentials of diet and lifestyle, as measured by the Dietary Inflammation Score (DIS) and Lifestyle Inflammation Score (LIS), with the ...